Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2009
10/08/2009WO2009122443A2 A tumor model system useful to study multistage cancer
10/08/2009WO2009122441A2 Method of cloning stable stress tolerant superoxide dismutase using universal primers
10/08/2009WO2009122401A2 Methods of expressing a polypeptide in the brain and nucleic acid constructs capable of same
10/08/2009WO2009121999A1 Specific promoter of stem cells
10/08/2009WO2009121994A1 Fusion proteins having a beta-trefoil-type lectin domain, method for obtaining same and use thereof
10/08/2009WO2009121804A1 Drug fusions and conjugates
10/08/2009WO2009121536A1 Method of treating genetic disorders
10/08/2009WO2009121208A1 Reagents, chaotropic agents, kits and methods for isolating nucleic acids based on magnetic cellulose materials
10/08/2009WO2009121176A1 Insulin-induced gene (insig) peptide compositions and methods for cytoprotection
10/08/2009WO2009121157A1 Vectors containing the max gene
10/08/2009WO2009102894A3 Arginine-conjugated bioreducible poly (disulfide amine) polymers for gene delivery systems
10/08/2009WO2009102438A3 Aptamer inhibitors of osteopontin and methods of use thereof
10/08/2009WO2009101204A3 Elimination of immune responses to viral vectors
10/08/2009WO2009097351A9 TAK1-D MEDIATED INDUCTION OF CELL DEATH IN HUMAN CANCER CELLS BY SPECIFIC SEQUENCE SHORT DOUBLE STRANDED RNAs
10/08/2009WO2009094772A8 Methods and apparatus for particle introduction and recovery
10/08/2009WO2009094006A3 Bordetella outer-membrane protein antigens and methods of making and using the same
10/08/2009WO2009091904A3 Microrna based methods and compositions for the treatment of cancer
10/08/2009WO2009091720A3 N-linked glycosylation alteration in e1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
10/08/2009WO2009091659A3 Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
10/08/2009WO2009091141A3 Recombinant microorganism having a producing ability of polylactate or its copolymers and method for preparing polylactate or its copolymers using the same
10/08/2009WO2009089399A3 Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection
10/08/2009WO2009088950A3 Pcv2 orf2 virus like particle with foreign amino acid insertion
10/08/2009WO2009088256A3 Baculovirus-based vaccines
10/08/2009WO2009086116A3 Alternative scaffold protein fusions phage display via fusion to plx of m13 phage
10/08/2009WO2009077611A3 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm)
10/08/2009WO2009068588A3 Transgenic plants with increased stress tolerance and yield
10/08/2009WO2008045148A8 Protease screening methods and proteases identified thereby
10/08/2009WO2001098526A9 Receptor fingerprinting, sensory perception, and biosensors of chemical sensants
10/08/2009WO2001025256A3 Trdl-1-gamma, a novel tumor necrosis-like ligand
10/08/2009US20090255013 Use of virus induced gene silencing (VIGS) to down-regulate gene use in plants
10/08/2009US20090255012 Sweet pepper hybrid 9942595
10/08/2009US20090255011 Sweet pepper hybrid 9954288
10/08/2009US20090255010 Tomato hybrid bs 01031842
10/08/2009US20090255009 Cotton variety fm 9150f
10/08/2009US20090255008 Cotton variety fm 9180b2f
10/08/2009US20090255007 system for production of stable, genetically transformed maize cells; methods of achieving stable transformation include tissue culture methods and media, methods for bombardment of recipient cells with desired transforming DNA, and methods of growing fertile plants from transformed cells
10/08/2009US20090255005 Method for Preparing Fish Embryo
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090253952 Methods and Compositions for Improved Fertilization and Embryonic Survival
10/08/2009US20090253902 Isolation of a rearranged human immunoglobulin gene from a chimeric mouse and recombinant production of the encoded immunoglobulin
10/08/2009US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
10/08/2009US20090253780 COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER
10/08/2009US20090253778 DNA composition against tumor stromal antigen FAP and methods of use thereof
10/08/2009US20090253776 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
10/08/2009US20090253770 Target gene mimitin of myc
10/08/2009US20090253769 Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders
10/08/2009US20090253626 50 Human Secreted Proteins
10/08/2009US20090253619 Novel peptide involved in energy homeostasis
10/08/2009US20090253588 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
10/08/2009US20090253577 Wheat plants having increased resistance to imidazolinone herbicides
10/08/2009US20090253208 Genetic engineered herpes virus genomes; vaccine; gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus
10/08/2009US20090253207 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
10/08/2009US20090253206 Nuclear transport agent and method for producing said agent
10/08/2009US20090253205 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
10/08/2009US20090253203 Reprogramming a Cell by Inducing a Pluripotent Gene Through Use of a Small Molecule Modulator
10/08/2009US20090253192 Process for the biological production of 1,3-propanediol with high titer
10/08/2009US20090253189 Lactic Acid-Producing Yeast Cells Having Nonfunctional L- or D-Lactate:Ferricytochrome C Oxidoreductase Cells
10/08/2009US20090253185 Avipox recombinants expressing foot and mouth disease virus genes
10/08/2009US20090253184 Compositions and methods related to an adenoviral trans-complementing cell line
10/08/2009US20090253182 Fed-batch fermentation process and culture medium for the production of plasmid dna in e. coli on a manufacturing scale
10/08/2009US20090253179 Permitting the increased production of recombinant proteins; culturing; introducing into the cells agents that inhibit senescence or that promote cell survival
10/08/2009US20090253177 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength
10/08/2009US20090253176 Cell lines and methods for producing proteins
10/08/2009US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009US20090253173 Filamentous fungi with inactivated protease genes for altered protein production
10/08/2009US20090253172 Growth factor homolog zvegf4
10/08/2009US20090253171 Methods For Producing Secreted Polypeptides Having Biological Activity
10/08/2009US20090253169 Use of genetically modified organisms to generate biomass degrading enzymes
10/08/2009US20090253168 improving the membrane permeability of a substrate, hydantoin-transporter activity; obtained by introducing and expressing the novel gene called mhp
10/08/2009US20090253167 Methanol-responsive promoter, fusion gene comprising promoter and foreign gene connected so that foreign gene can be expressed, vector, transformant, and method of producing protein
10/08/2009US20090253164 E. coli for efficient production of caratenoids
10/08/2009US20090253152 NOVEL MUTANT IGFBP-3 MOLECULES THAT DO NOT BIND TO IGFs, BUT RETAIN THEIR ABILITY TO FUNCTIONALLY BIND IGFBP-3 RECEPTOR
10/08/2009US20090253136 Genetic risk assessment technology for epithelial cancer involving gene-environment interaction between ercc5 and tobacco use
10/08/2009US20090253135 POLYMORPHISMS OF THE BLyS GENE AND USE IN DIAGNOSTIC METHODS
10/08/2009US20090253131 Hybrid fusion reporter and uses thereof
10/08/2009US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
10/08/2009US20090253124 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA
10/08/2009US20090252860 Soybean Cultivar 7631014
10/08/2009US20090252859 Soybean Cultivar 7431014
10/08/2009US20090252858 Soybean Cultivar 7925084
10/08/2009US20090252857 Soybean Cultivar 7311153
10/08/2009US20090252856 Soybean Cultivar S070159
10/08/2009US20090252828 Alpha-amylase variants with altered properties
10/08/2009US20090252814 Use of xenon for organ protection
10/08/2009US20090252783 Means for inhibiting the expression of cd31
10/08/2009US20090252766 Attenuated gram negative bacteria
10/08/2009US20090252765 Bacille calmette-guerin (bcg)-based anti-atheroma vaccine and methods of use thereof
10/08/2009US20090252763 Biological adjuvants
10/08/2009US20090252761 Papilloma virus vaccine
10/08/2009US20090252760 Construction of Recombinant Adenovirus With Genes That Codify for SAG1, SAG2 and SAG3
10/08/2009US20090252755 nucleic acid molecule comprising a hepatitis C virus (HCV) 5' untranslated region (UTR), produces a HCV that infects chimpanzees; for screening assays for the identification of antiviral agents for HCV
10/08/2009US20090252752 Kdr peptides and vaccines comprising the same
10/08/2009US20090252750 Antibodies and immunotoxins that target human glycoprotein nmb
10/08/2009US20090252748 Sp35 Antibodies and Uses Thereof
10/08/2009US20090252747 Immunization; used to elicit a humoral or cellular immune response
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009US20090252735 Novel Peptides for Development of Diagnostic and Therapeutic Agents and Methods of Using Same
10/08/2009US20090252733 Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38
10/08/2009US20090252729 Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto